These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10423510)

  • 1. [The future of antifungal agents. Non azole antifungal agents].
    Maesaki S; Hossain MA; Sasaki E; Hashiguchi K; Higashiyama Y; Yoshitsugu Y; Tomono K; Tashiro T; Kohno S
    Nihon Ishinkin Gakkai Zasshi; 1999; 40(3):157-61. PubMed ID: 10423510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of FK463, a (1,3)-beta-D-glucan synthase inhibitor, in disseminated azole-resistant candida albicans infection in mice.
    Maesaki S; Hossain MA; Miyazaki Y; Tomono K; Tashiro T; Kohno S
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1728-30. PubMed ID: 10817741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antifungal activity and clinical efficacy of micafungin (funguard)].
    Ikeda F
    Nihon Ishinkin Gakkai Zasshi; 2005; 46(4):217-22. PubMed ID: 16282962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micafungin: a therapeutic review.
    Higashiyama Y; Kohno S
    Expert Rev Anti Infect Ther; 2004 Jun; 2(3):345-55. PubMed ID: 15482200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis.
    Ikeda F; Wakai Y; Matsumoto S; Maki K; Watabe E; Tawara S; Goto T; Watanabe Y; Matsumoto F; Kuwahara S
    Antimicrob Agents Chemother; 2000 Mar; 44(3):614-8. PubMed ID: 10681327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antifungal activity and clinical efficacy of micafungin sodium (Funguard)].
    Ikeda F
    Nihon Yakurigaku Zasshi; 2003 Oct; 122(4):339-44. PubMed ID: 14501170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.
    Warn PA; Morrissey G; Morrissey J; Denning DW
    J Antimicrob Chemother; 2003 Apr; 51(4):913-9. PubMed ID: 12654746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative evaluation of properties and clinical efficacy of the echinocandins.
    Kim R; Khachikian D; Reboli AC
    Expert Opin Pharmacother; 2007 Jul; 8(10):1479-92. PubMed ID: 17661730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antifungal activity of a novel lipopeptide antifungal agent, FK463, against various fungal pathogens.
    Uchida K; Nishiyama Y; Yokota N; Yamaguchi H
    J Antibiot (Tokyo); 2000 Oct; 53(10):1175-81. PubMed ID: 11132964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits.
    Petraitis V; Petraitiene R; Groll AH; Roussillon K; Hemmings M; Lyman CA; Sein T; Bacher J; Bekersky I; Walsh TJ
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1857-69. PubMed ID: 12019101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro activity of a new semisynthetic echinocandin, micafungin, against clinical isolates of Candida species isolated in Tenri Hospital].
    Komatsu M; Aihara M; Shimakawa K; Iwasaki M; Nagasaka Y; Fukuda S; Abe N; Matsuo S
    Jpn J Antibiot; 2003 Dec; 56(6):705-11. PubMed ID: 15007879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal mechanism of FK463 against Candida albicans and Aspergillus fumigatus.
    Hatano K; Morishita Y; Nakai T; Ikeda F
    J Antibiot (Tokyo); 2002 Feb; 55(2):219-22. PubMed ID: 12003006
    [No Abstract]   [Full Text] [Related]  

  • 13. The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis.
    Melkusová S; Bujdáková H; Volleková A; Myoken Y; Mikami Y
    Pharmazie; 2004 Jul; 59(7):573-4. PubMed ID: 15296100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The echinocandin micafungin: a review of the pharmacology, spectrum of activity, clinical efficacy and safety.
    Wiederhold NP; Lewis JS
    Expert Opin Pharmacother; 2007 Jun; 8(8):1155-66. PubMed ID: 17516879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New antifungal agents].
    Miyazaki Y; Kawano S
    Jpn J Antibiot; 2002 Dec; 55(6):911-2. PubMed ID: 12664932
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of the growth medium on the in vitro antifungal activity of micafungin (FK-463) against clinical isolates of Candida dubliniensis.
    Müller FM; Kurzai O; Hacker J; Frosch M; Mühlschlegel F
    J Antimicrob Chemother; 2001 Nov; 48(5):713-5. PubMed ID: 11679561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi.
    Tawara S; Ikeda F; Maki K; Morishita Y; Otomo K; Teratani N; Goto T; Tomishima M; Ohki H; Yamada A; Kawabata K; Takasugi H; Sakane K; Tanaka H; Matsumoto F; Kuwahara S
    Antimicrob Agents Chemother; 2000 Jan; 44(1):57-62. PubMed ID: 10602723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of micafungin in the antifungal armamentarium.
    Ikeda F; Tanaka S; Ohki H; Matsumoto S; Maki K; Katashima M; Barrett D; Aoki Y
    Curr Med Chem; 2007; 14(11):1263-75. PubMed ID: 17504145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of SPK-843, a novel polyene antifungal, in comparison with amphotericin B, liposomal amphotericin B, and micafungin against murine pulmonary aspergillosis.
    Kakeya H; Miyazaki Y; Senda H; Kobayashi T; Seki M; Izumikawa K; Yanagihara K; Yamamoto Y; Tashiro T; Kohno S
    Antimicrob Agents Chemother; 2008 May; 52(5):1868-70. PubMed ID: 18299412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antifungal activity of FK463, a new water-soluble echinocandin-like lipopeptide.
    Mikamo H; Sato Y; Tamaya T
    J Antimicrob Chemother; 2000 Sep; 46(3):485-7. PubMed ID: 10980180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.